Drugs / HCP1401
last change Nov 2015 re-read 2 minutes ago

HCP1401

Investigated by
Hanmi Pharmaceutical Company Limited

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04252872 Aug → Nov 2015 Hanmi Pharmaceutical Company Limited Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HCP1401 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04252872
Route Oral Oral Single Dose” NCT04252872